Table 2 Univariate logistic regression model for factors related to bleeding risk potentially affecting the selection of a particular TPO-RA. OR indicates the probability of choosing romiplostim over eltrombopag.

From: Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia

 

OR

95% CI

P

Bleeding at diagnosis

2.7

1.29–5.73

0.009

Bleeding score at diagnosis >2

2.9

1.25–6.57

0.013

Bleeding score when TPO-RA was started >1

2.5

1.18–5.46

0.017

Platelet count when TPO-RA was started ≤25 × 109/l

2.8

1.27–6.04

0.010

Need for unscheduled hospital care in the previous 6 months

2.7

1.27–5.74

0.010

  1. Abbreviations: TPO-RA, thrombopoietin receptor agonist.
Back to article page